• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tie受体及其血管生成素配体是血管重塑的背景依赖性调节因子。

Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling.

作者信息

Eklund Lauri, Olsen Bjorn R

机构信息

Harvard School of Dental Medicine, Department of Oral and Developmental Biology, 188 Longwood Avenue, REB, 4th floor, Boston, MA 02115, USA.

出版信息

Exp Cell Res. 2006 Mar 10;312(5):630-41. doi: 10.1016/j.yexcr.2005.09.002. Epub 2005 Oct 12.

DOI:10.1016/j.yexcr.2005.09.002
PMID:16225862
Abstract

Angiopoietins are ligands of the Tie2 receptor that control angiogenic remodeling in a context-dependent manner. Tie signaling is involved in multiple steps of the angiogenic remodeling process during development, including destabilization of existing vessels, endothelial cell migration, tube formation and the subsequent stabilization of newly formed tubes by mesenchymal cells. Beyond this critical role in blood vessel development, recent studies suggest a wider role for Tie2 and angiopoietins in lymphangiogenesis and the development of the hematopoietic system, as well as a possible role in the regulation of certain non-endothelial cells. The outcome of Tie signaling depends on which vascular bed is involved, and crosstalk between different VEGFs has an important modulating effect on the properties of the angiopoietins. Signaling through the Tie1 receptor is not well understood, but Tie1 may have both angiopoietin-dependent and ligand-independent functions. Changes in the expression of Tie receptors and angiopoietins occur in many pathological conditions, and mutations in the Tie2 gene are found in familial cases of vascular disease.

摘要

血管生成素是Tie2受体的配体,以一种依赖于环境的方式控制血管生成重塑。Tie信号通路参与发育过程中血管生成重塑的多个步骤,包括现有血管的不稳定、内皮细胞迁移、管腔形成以及随后间充质细胞对新形成管腔的稳定作用。除了在血管发育中的这一关键作用外,最近的研究表明Tie2和血管生成素在淋巴管生成和造血系统发育中具有更广泛的作用,以及在某些非内皮细胞的调节中可能发挥作用。Tie信号通路的结果取决于所涉及的血管床,不同血管内皮生长因子(VEGF)之间的相互作用对血管生成素的特性具有重要的调节作用。通过Tie1受体的信号传导尚不清楚,但Tie1可能具有依赖血管生成素和不依赖配体的功能。Tie受体和血管生成素的表达变化发生在许多病理状态下,并且在家族性血管疾病病例中发现了Tie2基因的突变。

相似文献

1
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling.Tie受体及其血管生成素配体是血管重塑的背景依赖性调节因子。
Exp Cell Res. 2006 Mar 10;312(5):630-41. doi: 10.1016/j.yexcr.2005.09.002. Epub 2005 Oct 12.
2
The role of Ang/Tie signaling in lymphangiogenesis.Ang/Tie 信号在淋巴管生成中的作用。
Lymphology. 2010 Jun;43(2):59-72.
3
Angiopoietins and angiopoietin-like proteins in angiogenesis.血管生成中的血管生成素和血管生成素样蛋白。
Endothelium. 2006 Mar-Apr;13(2):71-9. doi: 10.1080/10623320600697989.
4
The role of the Angiopoietins in vascular morphogenesis.血管生成素在血管形态发生中的作用。
Angiogenesis. 2009;12(2):125-37. doi: 10.1007/s10456-009-9147-3. Epub 2009 May 16.
5
Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking.血管生成素-Tie和ephrin-Eph系统作为细胞转运调节因子的新作用。
J Leukoc Biol. 2006 Oct;80(4):719-26. doi: 10.1189/jlb.1105652. Epub 2006 Jul 24.
6
Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.血管内皮生长因子激活受体酪氨酸激酶的Tie家族。
Cell Signal. 2009 Aug;21(8):1346-50. doi: 10.1016/j.cellsig.2009.04.002. Epub 2009 Apr 17.
7
[The regulating roles of angiopoietins/TEK-2 in angiogenesis].[血管生成素/TEK-2在血管生成中的调节作用]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Feb;23(1):63-6.
8
Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis.血管生成素和Tie受体酪氨酸激酶在血管生成和淋巴管生成中的作用。
Cell Tissue Res. 2003 Oct;314(1):61-8. doi: 10.1007/s00441-003-0749-6. Epub 2003 Aug 12.
9
Angiopoietins and Tie2 in health and disease.血管生成素与Tie2在健康与疾病中的作用
Pediatr Endocrinol Rev. 2005 Mar;2(3):399-408.
10
Angiopoietins in angiogenesis.血管生成素在血管生成中的作用。
Cancer Lett. 2013 Jan 1;328(1):18-26. doi: 10.1016/j.canlet.2012.08.018. Epub 2012 Aug 23.

引用本文的文献

1
Genetic mutation and blue rubber bleb nevus syndrome: case reports and literature review.基因突变与蓝色橡皮疱痣综合征:病例报告及文献综述
Front Genet. 2025 Jun 13;16:1516562. doi: 10.3389/fgene.2025.1516562. eCollection 2025.
2
NNMT/1-MNA protects against hepatic ischemia-reperfusion injury through the AKT/FOXO1/ANGPT2/JNK axis.NNMT/1-MNA通过AKT/FOXO1/ANGPT2/JNK轴预防肝缺血再灌注损伤。
Nat Commun. 2025 May 22;16(1):4779. doi: 10.1038/s41467-025-59968-9.
3
DOCK9 as a predictive biomarker linked to angiogenesis and immune response in esophageal squamous cell carcinoma.
DOCK9作为一种与食管鳞状细胞癌血管生成和免疫反应相关的预测性生物标志物。
Clin Exp Med. 2025 Apr 24;25(1):126. doi: 10.1007/s10238-025-01653-8.
4
Immune-privileged cord blood-derived endothelial colony-forming cells: advancing immunomodulation and vascular regeneration.免疫特权的脐带血来源内皮祖细胞:推动免疫调节和血管再生
Angiogenesis. 2025 Mar 6;28(2):19. doi: 10.1007/s10456-025-09973-9.
5
Inhibition of Angiopoietin-2 rescues sporadic brain arteriovenous malformations by reducing pericyte loss.血管生成素-2的抑制通过减少周细胞丢失挽救散发性脑动静脉畸形。
Angiogenesis. 2024 Dec 5;28(1):3. doi: 10.1007/s10456-024-09957-1.
6
Flavonoid-Mediated Suppression of Tumor Angiogenesis: Roles of Ang-Tie/PI3K/AKT.类黄酮介导的肿瘤血管生成抑制:血管生成素-酪氨酸激酶/磷脂酰肌醇-3激酶/蛋白激酶B的作用
Pathophysiology. 2024 Oct 12;31(4):596-607. doi: 10.3390/pathophysiology31040043.
7
Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations.多梳抑制复合物 1 的表观遗传调控促进脑动静脉畸形的发生。
EMBO Mol Med. 2024 Nov;16(11):2827-2855. doi: 10.1038/s44321-024-00152-9. Epub 2024 Oct 14.
8
Beyond VEGF: Angiopoietin-Tie Signaling Pathway in Diabetic Retinopathy.超越血管内皮生长因子:糖尿病视网膜病变中的血管生成素-Tie信号通路
J Clin Med. 2024 May 9;13(10):2778. doi: 10.3390/jcm13102778.
9
Shear stress and pathophysiological PI3K involvement in vascular malformations.切应力与血管畸形中的病理生理学 PI3K 相关
J Clin Invest. 2024 May 15;134(10):e172843. doi: 10.1172/JCI172843.
10
Site-specific periosteal cells with distinct osteogenic and angiogenic characteristics.具有独特成骨和血管生成特性的位点特异性骨膜细胞。
Clin Oral Investig. 2023 Dec;27(12):7437-7450. doi: 10.1007/s00784-023-05333-3. Epub 2023 Oct 17.